Skip to content

BIOCRYST PHARMACEUTICALS, INC.: filings

Every BIOCRYST PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026451260001628280-26-053300
10-Q2026-05-06fiscal Q1 202645940001628280-26-031238
10-K2026-02-26fiscal FY 2025471240001628280-26-012240
10-Q2025-11-04fiscal Q3 2025421210001628280-25-048785
10-Q2025-08-05fiscal Q2 2025421170001628280-25-037795
10-Q2025-05-06fiscal Q1 202541850001628280-25-022658
10-K2025-02-25fiscal FY 2024451170001628280-25-007715
10-Q2024-11-05fiscal Q3 2024401140001628280-24-045364
10-Q2024-08-06fiscal Q2 2024391080001628280-24-035170
10-Q2024-05-07fiscal Q1 202439800001628280-24-021069
10-K2024-02-27fiscal FY 2023451150001628280-24-007205
10-Q2023-11-08fiscal Q3 2023381120001628280-23-037847
10-Q2023-08-07fiscal Q2 2023381080001628280-23-027820
10-Q2023-05-08fiscal Q1 202338780001628280-23-016458
10-K2023-02-27fiscal FY 2022431080001628280-23-005259
10-Q2022-11-04fiscal Q3 2022381120001628280-22-028463
10-Q2022-08-05fiscal Q2 2022371060001628280-22-021373
10-Q2022-05-09fiscal Q1 202235720001171843-22-003423
10-K2022-02-28fiscal FY 202138950001171843-22-001460
10-Q2021-11-04fiscal Q3 202133890001171843-21-007570
10-Q2021-08-09fiscal Q2 202132840001171843-21-005674
10-Q2021-05-07fiscal Q1 202131640001171843-21-003310
10-K2021-03-01fiscal FY 202035960001171843-21-001411
10-Q2020-11-06fiscal Q3 202032870001171843-20-007740
10-Q2020-08-07fiscal Q2 202032830001171843-20-005753
10-Q2020-05-11fiscal Q1 202029590001171843-20-003557
10-K2020-03-13fiscal FY 201937980001171843-20-001710
10-Q2019-11-08fiscal Q3 201934890001171843-19-007384
10-Q2019-08-08fiscal Q2 201933840001171843-19-005326
10-Q2019-05-09fiscal Q1 201933660001171843-19-003220
10-K2019-03-14fiscal FY 201835960001171843-19-001727
10-Q2018-11-08fiscal Q3 201832770001171843-18-007788
10-Q2018-08-09fiscal Q2 201832760001171843-18-005928
10-Q2018-05-09fiscal Q1 201832620001171843-18-003719
10-K2018-03-12fiscal FY 201736990001171843-18-001855
10-Q2017-11-08fiscal Q3 201733830001171843-17-006746
10-Q2017-08-08fiscal Q2 201730770001171843-17-004830
10-Q2017-05-08fiscal Q1 201730610001171843-17-002784
10-K2017-02-27fiscal FY 201634940001171843-17-001159
10-Q2016-11-08fiscal Q3 201629750001171843-16-013033
10-Q2016-08-08fiscal Q2 201632870001171843-16-011576
10-Q2016-05-09fiscal Q1 201628570001171843-16-009811
10-K2016-02-26fiscal FY 201532930001171843-16-008207
10-Q2015-11-06fiscal Q3 201528720001171843-15-006102
10-Q2015-08-07fiscal Q2 201531850001171843-15-004473
10-Q2015-05-08fiscal Q1 201525500001171843-15-002688
10-K2015-03-02fiscal FY 201428800001171843-15-001186
10-Q2014-11-07fiscal Q3 201426680001171843-14-005367
10-Q2014-08-08fiscal Q2 201426680001171843-14-003839
10-Q2014-05-09fiscal Q1 201426530001193125-14-192102
10-K2014-03-10fiscal FY 201330840001193125-14-091609
10-Q2013-11-08fiscal Q3 201326680001193125-13-434942
10-Q2013-08-08fiscal Q2 201326680001193125-13-326993
10-Q2013-05-09fiscal Q1 201326540001193125-13-210965
10-K2013-03-11fiscal FY 201231850001193125-13-100999
10-Q2012-11-08fiscal Q3 201227690001193125-12-460637
10-Q2012-08-08fiscal Q2 201227690001193125-12-343906
10-Q2012-05-08fiscal Q1 201226520001193125-12-218117
10-K2012-03-06fiscal FY 201126650001193125-12-098926
10-Q2011-11-03fiscal Q3 201126610001193125-11-295412
10-Q2011-08-04fiscal Q2 201126610000950123-11-072999

Inspect the source

Entity
BIOCRYST PHARMACEUTICALS, INC. / CIK 0000882796
Captured
2026-09-20T05:02:04.268Z
SEC response SHA-256
64fec42b290a9661564adfbe60f6de7df3ea9fe9bff3ac7d73b79819a05c52a5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000882796.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))